Evaluation of IGF1/IGFBP3 Molar Ratio as an Effective Tool for Assessing the Safety of GH Therapy in Small-For-Gestational-Age, GH-Deficient and Prader-Willi Children
JCRPE Journal of Clinical Research in Pediatric Endocrinology - Turkey
doi 10.4274/jcrpe.galenos.2019.2018.0277
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2019
Authors
Publisher
Galenos Yayinevi